The objective is to have sessions focused on community mobilization and movement building, community-led monitoring, renewed strategies around safety and advocacy; governance structures and processes of CLOs (new models, reforming, ensuring representation and accountability towards our communities); Sustainability - capacity to respond to and mitigate against future changes, ideological and political threats. Safety (digital and physical) and mental health of activists. Resource mobilization efforts, Community-led innovation (digitalization, new technologies, new fundraising strategies). 

 Day 2: Rights and Decriminalization 

Counteracting stigmatization and demonizing narratives around HIV and Key Populations, through representation, research, information provision, media, and digital campaigning. Working with wider SRHR and social justice movements to coordinate joint efforts. Advocacy for improved legal protection from discrimination. Intersectionality: working with partners to conduct research and advocacy and movement building. Engaging with the scientific, public health and academic fields to limit stigmatizing narratives and promote rights-based approaches. Self-stigma and mental health improvement strategies.  

 Day 3: Intersectionality, Leadership, and Innovation

The objective is to engage and empower the next generation of intersectional HIV advocates and support innovation and the future. We aim to focus on the future of innovation and intersectional leadership in the HIV response. We want to create opportunities to explore intersectional leadership from the perspectives of young women, and youth from key populations, as well as explore the future of activism, social media and the emergence of key innovations including digital tech and rights.  

 Day 4: Access to Treatment and Services

 The objective is to have discussions focused on international and national regulation to strengthen treatment access and accountability of pharmaceutical industry.  Interventions focused on issues of stock outs, poor access to diagnostics, limited access for certain “left behind” populations (key populations, children, pregnant women). Best practices of education and treatment literacy. Involvement in processes to ensure comprehensive care that includes HIV prevention and treatment, SRHR, TB, mental health and Hepatitis, cervical cancer, meningitis, ageing with HIV and U=U model.  

Day 5: Sustaining the HIV Response Amidst Global Challenges 

The objective is to have sessions focused on strategies, advocacy, and interventions (and CLOs role) aimed on the HIV response to be prioritised, ensuring it remains financially sustainable, and has capacity to respond to and mitigate against future changes, emergencies, and other priorities (including in policymaking on Universal Health Coverage, Pandemic Preparedness, Transitioning, Sustainability and humanitarian response). Healthcare interventions (with focus on CLOs interventions) connected with climate change, pandemics, armed conflicts, wars, humanitarian situations of nature kind. Interventions focused a wide range of HIV sensitive/competent programmes for migrants, including those who are undocumented, and refugees. Best practices of technical and fundraising support to local PLHIV and KP (Key Populations) networks coordinating direct help on the ground in times of crisis.   

*****